Capstone Investment Advisors
PTLA

Capstone Investment Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Capstone Investment Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-166,055
Closed -$2.99M – 1485
2020
Q2 		$2.99M Buy
+166,055
New +$2.31M 0.02% 582
2017
Q4 		– Sell
-6,548
Closed -$353K – 713
2017
Q3 		$353K Buy
+6,548
New +$384K 0.01% 372

Capstone Investment Advisors's PTLA Position: Q3 2020 in Review

Capstone Investment Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 166,055 shares — an estimated $2.99M sold.

Capstone Investment Advisors first reported a position in PTLA in Q3 2017 and held it in 2 quarters. The position peaked at $2.99M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Capstone Investment Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Capstone Investment Advisors sold 166,055 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.99M.
  • Capstone Investment Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
  • Capstone Investment Advisors's Portola Pharmaceuticals, Inc. position peaked at $2.99M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Capstone Investment Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.